PTCT Stock Analysis: Buy, Sell, or Hold?
PTCT - PTC Therapeutics, Inc.
$83.31
1.96 (2.41%)
▲
5d:
-1.42%
30d:
+22.1%
90d:
+21.18%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When PTCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PTCT shows positive signals but monitor for confirmation. Market pricing in 3.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: PTCT shows positive signals but monitor for confirmation. Market pricing in 3.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$135.50
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$84.14
1.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PTCT is currently trading at $83.31, which is considered extended relative to its 30-day fair value range of $70.72 to $81.51. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.9) compared to its historical average (27.0). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PTCT is in a uptrend. Immediate support is located at $78.10, while resistance sits at $87.03.
Market Sentiment: PTCT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.93 (+12.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PTCT is in a uptrend. Immediate support is located at $78.10, while resistance sits at $87.03.
Market Sentiment: PTCT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.93 (+12.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$70.72 -
$81.51
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($93.93)
- NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$70.72 -
$81.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$78.10
Resistance Level
$87.03
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.93
Wall Street Target
$93.93
(+12.7%)
Revenue Growth (YoY)
-76.8%
Profit Margin
-22.6%
Valuation Premium vs History
+3.4% premium
PE vs Historical
29.9 vs 27.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$86.14
(+3%)
2-Year Target
$89.07
(+7%)
3-Year Target
$92.10
(+11%)
3-Yr Target (if PE normalizes)
(PE: 30→27)
PE COMPRESSION
$83.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.9, Growth: 111.9%)
$281.17
(+238%)
Base:
(SPY PE: 21.8, Growth: 111.9%)
$204.59
(+146%)
Bear:
(PE: 18.5, Growth: 111.9%)
$173.90
(+109%)
Share & Embed Analysis
Last updated: July 03, 2026 3:47 PM ET
Data refreshes hourly during market hours. Next update: 4:47 PM
Data refreshes hourly during market hours. Next update: 4:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Matthew B Klein
SELL
2850 shares
2026-04-21
Mark Elliott Boulding
SELL
2265 shares
2026-04-06
Lee Scott Golden
SELL
829 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
Advanced PTCT Option Strategies
Professional options setups generated by AI based on today's PTCT price and gamma walls.
